Jim Cramer on Huntington Ingalls: “It Is the Best Thing We Have When It Comes to the Navy”
“Jim Cramer’s recent endorsement of Huntington Ingalls Industries (HII) as ‘the best thing we have when it comes to the…
Author: MJ K
Canadian Investment Regulatory Organization Trade Resumption: Navigating Halts in Canadian Markets
“The Canadian Investment Regulatory Organization (CIRO) plays a pivotal role in maintaining orderly markets by imposing trading halts on individual…
Vanda Pharmaceuticals’ Imsidolimab BLA Accepted by FDA for Generalized Pustular Psoriasis Treatment
Vanda Pharmaceuticals has received FDA acceptance for its Biologics License Application (BLA) seeking approval of imsidolimab as a treatment for…
Texas Instruments (TXN) Fell Due to Quicker Recovery Expectation
Texas Instruments’ shares declined recently as investors adjusted expectations around the pace of recovery in its end markets. Despite positive…
The Deep Learning Market is Poised for Explosive Growth, Reaching $296 Billion by 2031
The global deep learning market, valued at approximately $64.92 billion in 2026, is on track to surpass $296 billion by…
Delta Resources Solidifies Financing, Capital Markets and Project Development Strength with the Appointment of Ron Kopas as CEO and Technical Depth with Daniel Boudreau to Vice President of Exploration
Delta Resources Limited has strengthened its leadership team with the appointment of Ron Kopas as Chief Executive Officer, bringing extensive…
The title of the article is: ETP Securityholders Face Adjournment in Vote on Principal Amount Amendment Amid Low Value Threshold Breach
“The recent announcement regarding the adjournment of the ETP securityholders’ meeting highlights ongoing challenges for leveraged and inverse exchange-traded products…
Global Market’s Top Value Stock Opportunities In February 2026
“As markets navigate a rotation from growth to value amid steady global growth forecasts of around 2.8%, undervalued opportunities emerge…
Paul Efron, Former Goldman Sachs General Partner, Joins Star Mountain Capital as Senior Advisor
“In a strategic move that bolsters its advisory expertise, Star Mountain Capital has welcomed Paul Efron, a longtime Goldman Sachs…
Protagonist Therapeutics Director Sells 20,000 Shares Amid Strong Stock Performance
In a recent insider transaction, Protagonist Therapeutics director William D. Waddill exercised stock options and sold 20,000 shares of PTGX…